tumor localization systems, tumor localization, elekta, radiation therapy

Elekta X-ray Volume Imaging (XVI)


September 13, 2013 – Integrated with Versa HD linear accelerator, Elekta has introduced new intra-fraction imaging capabilities within its X-ray Volume Imaging (XVI) system. During treatment, XVI now provides the tools to monitor and manage internal motion, supporting the clinician's efforts to increase therapeutic doses delivered to the tumor while reducing healthy tissue exposure.

"Regardless of patient immobilization, both the tumor and adjacent critical structures may move during treatment delivery. Historically, this has presented a significant challenge in delivering highly targeted treatments," says Dee Mathieson, Senior Vice President, Oncology Business Line Management.

"On a second by second basis, the precise location of the tumor and sensitive healthy structures can now be visualized, helping clinicians accurately deliver dose to the tumor while minimizing normal tissue exposure,” she adds

Elekta's XVI, which is also available on other Elekta radiotherapy delivery systems, includes 2-D, 3-D and 4-D intra-fraction imaging to support live imaging during sophisticated delivery techniques, such as Volumetric Modulated Arc Therapy (VMAT).

The new capabilities within XVI include seamless integration with Elekta's Mosaiq image-enabled oncology information system. XVI and Mosaiq work in harmony to deliver highly automated imaging workflow for improved control, efficiency, and performance. With image data available within the Oncology Information System, patient images, as well as setup and correction data, can be accessed as an integral part of the patient's electronic medical record.

The XVI 5.0 is pending FDA 510(k) clearance and not yet available for sale in the United States.


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now